Savill Corrine bought CGEM
February 19, 2025 · Form 4 insider transaction
Savill Corrine bought 75,000 shares of Cullinan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderSavill Corrine
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2025
Filing dateFebruary 21, 2025
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.